Compugen Ltd.

US$1.96As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:CGENHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (10.18%)
Div yield —
ROE 50.64%
Biotechnology
Beta (5Y) 2.82
PE TTM 5.250
TSR TTM 10.73%
Mkt cap US$185.7M
ROIC 26.12%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2.07
5.40%
(17.35%)
Hold 6|12|10|1|9
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.02
0.02
0.03
0.03
(7.65%)
(2.30%)
4.42%
21.17%
Revenue$M
21.61
21.85
21.28
22.18
1.60%
(2.82%)
(6.23%)
(0.36%)
Peers (US$185.7M)
Cap (US$)
PE
203.6M
—
124.7M
—
Capital
TTM
5Y
10Y
Leveragex
2.037
0.086
0.117
EBIT/Intx
1.559
0.338
0.315
Own earn%
34.44
(5.78)
(13.72)
Sh yield%
33.71
33.75
34.31
Owners
Insiders/Inst%
14.43
40.42
Short interest%
2.40
SBC / revenue%
4.33
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
14
Op margin range%
20–26
$1 testx
—
Incr. ROIC%
5